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Abstract: A number of trials have been undertaken to assess whether the intake of  
omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) during pregnancy can 
influence the neurological development of the offspring, yet no consensus from these trials 
has been reached. We aimed to investigate the long-term effects (12 years) of fish oil 
supplementation in pregnancy on neurodevelopment, including cognition, language and fine 
motor skills. In a follow up of a previously published randomised controlled trial of  
98 pregnant women, their children were assessed at 12 years of age using a battery of 
neurodevelopmental assessments. Fifty participants were assessed at 12 years, with  
25 participant’s mothers receiving fish oil supplementation, and 25 receiving control 
capsules. There were no significant differences for any of the assessment measures 
completed. Our data indicate that fish oil supplementation during pregnancy does not 
influence the cognition, language or fine motor skills of children in late primary school  
(12 years of age). 
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1. Introduction  
Omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) are thought to be essential for normal 
neurological development, and are derived from the mother during gestation and breastfeeding. There is 
concern for potential insufficiencies of n-3 LCPUFA during critical periods of fetal neurological 
development, as maternal diets in Western nations are low in n-3 LCPUFA. A number of observational 
studies and randomised controlled trials (RCTs) have been undertaken to assess whether the intake of n-3 
LCPUFA during pregnancy can influence the neurological development of the offspring, yet no consensus 
from these trials has been reached. Our previous randomized controlled trial, in which pregnant women 
were allocated to receive fish oil capsules (2.2 g DHA, 1.1 g EPA per day) or olive oil from 20 weeks 
gestation until delivery of their baby, demonstrated that children born of mothers randomised to the fish oil 
group had statistically significantly higher hand-eye coordination at 2½ years when compared to controls [1]. 
We now report the neurodevelopmental outcomes of this cohort at 12 years. This represents the longest 
follow-up of a maternal n-3 LCPUFA supplementation study to date. Moreover, at this stage of 
individual development psychometric test data offer greater predictive value with respect to future  
adult performance.  
2. Method 
The trial methods were previously published [1]. All study procedures were conducted with written 
informed consent, as approved by the Princess Margaret Hospital (PMH) Human Research Ethics 
Committee. At 12 years of age, all study participants who had not previously withdrawn from the study 
were invited to attend an appointment. Assessment consisted of a battery of tests of cognitive function, 
language, behaviour and fine-motor control; testing was conducted at the Children’s Clinical Research 
Facility at Princess Margaret Hospital (CCRF) and performed by a single assessor who was blinded to 
group allocation (October 2012-December 2013). The primary outcome was Full-Scale IQ measure of 
the Wechsler Intelligence Scale for Children-IV (WISC-IV) [2]; and secondary outcomes included 
subtest scores on the WISC-IV, the Child Behaviour Checklist (CBCL, both parent and child forms) [3], 
the Beery-Buktenica Developmental Test of Visual-Motor Integration (TVMI) [4] and the Children’s 
Communication Checklist [5]. Information about children’s allergic disease and metabolic health and a 
blood sample were collected as part of ongoing parallel study. Phospholipid fatty acid composition was 
measured in erythrocyte cell membranes on available samples according to a previously published 
method ([6]). Statistical analyses were completed using SPSS Version for PC (Version 20). Analyses 
were completed on an intention-to-treat basis for participants who consented to follow-up. Independent 
group’s t-test and linear regression was used for data which were normally distributed, while the  
Mann-Whitney U test was used for data which could not be normalised. Fatty acid data was analysed 
using multivariable linear regression. Statistical significance was assessed at the 2-sided p ≤ 0.05 level. 
Adjustments were made for parity, sex and maternal education.  
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3. Results  
3.1. Population Characteristics 
Of the 72 participants who completed the previous follow-up at 2½ years of age, 50 participants 
attended the present follow-up at 12 years of age. An additional three participants who did not attend the 
2½ year visit did attend the 12 year assessment. In total, there were therefore 25 participants in each 
treatment group). This represents a loss of 22 participants from the previous follow-up (see Figure 1). 
Although loss to follow-up is typical of that reported in many randomised control studies [7], the 
reduction in power requires cautious interpretation of the findings. The number and proportion of 
children who had received the fish oil supplement and the placebo were equal, and there were no major 
differences in the baseline characteristics of the children who were lost to follow up compared with those 
who returned aged 12 years, with the exception of birth weight (Table S1). A significant difference was 
observed between the participants who did not attend and the original cohort for birth weight (with the 
cohort who completed the 12 year visit having a mean lower birth weight than the complete cohort). 
However, as both groups had means within the normal range for birth weight, this variable was not 
controlled for in the present statistical analyses.  
 
Figure 1. Trial design and participant retention. 
3.2. Neurodevelopmental Finding  
At 12 years of age, there were no significant differences between the groups for the primary or 
secondary analysis, either using adjusted (i.e., relative to normative data) or unadjusted data (See Table 1).  
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Table 1. Mean composite scores and percentile ranks for both supplementation groups *.  
Measure Mean Composite 
Score 
Mean Composite 
Scores 
Significance 
Adjusted 
Significance 
WISC-IV Composite Fish Oil (n = 25) Placebo (n = 25)   
Verbal Comprehension 105.2 (13.7) 107.1 (12.2) 0.618 0.738 
Perceptual Reasoning 110.2 (12.1) 109.6 (9.9) 0.859 0.667 
Working Memory 101.9 (11.7) 99.6 (7.8) 0.420 0.522 
Processing Speed 107.0 (13.0) 104.4 (11.7) 0.455 0.537 
Full Scale IQ 108.6 (12.2) 107.6 (9.9) 0.762 0.670 
Beery-Buktenika TVMI Fish Oil (n = 24) Placebo (n = 23)   
Beery VMI Standard Score 104.4 (9.0) 103.2 (9.9) 0.655 0.232 
Beery VMI Percentiles 60.9 (20.8) 57.6 (20.1) 0.583 0.192 
CBCL Parent-Report Fish Oil (n = 23) Placebo (n = 25)   
Internalising Behaviours 46.7 (8.7) 48.3 (9.5) 0.541 0.760 
Externalising Behaviours 46.4 (7.7) 42.6 (7.2) 0.090 0.051 
Total Behaviours Score 46.4 (8.2) 47.2 (7.4) 0.796 0.890 
Total Competence Score 52.2 (8.6) 52.4 (12.9) 0.634 0.540 
CBCL Child-Self Report Fish Oil (n = 22) Placebo (n = 25)   
Internalising Behaviours 47.4 (9.6) 47.0 (6.5) 0.940 0.409 
Externalising Behaviours 42.9 (9.6) 42.5 (6.9) 0.974 0.550 
Total Behaviours Score 47.5 (9.2) 45.1 (7.5) 0.527 0.141 
Total Competence Score 53.5 (9.6) 50.5 (11.9) 0.386 0.358 
Children’s Communication 
Checklist (CCC-2) 
Fish Oil (n = 22) Placebo (n = 25)   
GCC Percentile Rank 54.5 (27.6) 52.3 (27.5) 0.773 0.866 
* Scores are represented as mean (SD) unless otherwise stated. 
3.3. Fatty Acid Analysis 
At 12 years of age, a total of 43 participants (24 from the fish oil group, 19 from placebo) provided 
blood samples for fatty acid analyses. The n-3 LCPUFA measurements taken at 12 years were not 
significantly correlated with those from cord blood following supplementation (Table 2). Further, the 
fish oil and placebo groups did not significantly differ according to their n-3 LCPUFA status at 12 years 
(Table 3). This likely demonstrates the influence of n-3 LCPUFA consumption during the intervening 
12 years following supplementation.  
Interestingly, when erythrocyte DHA measurements at 12 years of age were associated with 
neurodevelopmental measures at 12 years (n = 40; 23 from fish oil group, 17 from placebo), significant 
positive associations were observed for several composite scores of the WISC-IV, including the Full 
Scale IQ. This effect persisted following adjustment for sex, maternal education and length of 
breastfeeding during infancy (Table 4).  
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Table 2. Correlation between n-3 LCPUFA in cord blood (post supplementation) and at  
12 years (n = 35).  
Fatty Acid Cord Blood 12 Years Pearson Correlation 
EPA (20:5n-3) (n = 35) 0.851 (0.63) 0.809 (0.22) −0.179, p = 0.304 
DHA (22:6n-3) (n = 43) 8.84 (1.7) 4.51 (0.88) 0.290, p = 0.059 
Table 3. Difference in n-3 LCPUFA at 12 years according to supplementation group  
during pregnancy. 
Fatty Acid Fish Oil (n = 24) Placebo (n = 19) Significance 
EPA (20:5n-3) 0.754 (0.16) 0.880 (0.27) 0.082 
DHA (22:6n-3) 4.65 (0.72) 4.34 (1.0) 0.266 
Table 4. Association between DHA and neurodevelopmental outcome at 12 years ^. 
Measure 
Unadjusted Analysis Adjusted Analysis 
β Significance β Significance 
WISC-IV Composite     
Verbal Comprehension 0.293 0.067 0.329 0.057 
Perceptual Reasoning 0.466 0.002 ** 0.332 0.042 * 
Working Memory 0.372 0.018 * 0.411 0.016 * 
Processing Speed 0.441 0.004 ** 0.332 0.042 * 
Full Scale IQ 0.522 0.001 ** 0.468 0.004 ** 
Beery-Buktenika TVMI     
Beery VMI Standard Score 0.046 0.784 −0.109 0.571 
Beery VMI Percentiles 0.037 0.823 −0.121 0.497 
CBCL Parent-Report     
Internalising Behaviours −0.026 0.878 −0.005 0.980 
Externalising Behaviours −0.003 0.985 0.031 0.869 
Total Behaviours Score −0.143 0.391 −0.030 0.866 
Total Competence Score 0.076 0.649 −0.051 0.780 
CBCL Child-Self Report     
Internalising Behaviours −0.255 0.128 −0.149 0.430 
Externalising Behaviours −0.181 0.283 −0.115 0.520 
Total Behaviours Score −0.232 0.168 −0.093 0.611 
Total Competence Score 0.134 0.428 0.173 0.380 
Children’s Communication Checklist (CCC-2)     
GCC Percentile Rank 0.006 0.972 −0.076 0.696 
^ Adjusted statistics controlled for maternal education, duration of breastfeeding in the first twelve months and child gender; 
* p < 0.05; ** p < 0.01. 
4. Discussion  
Our data indicate that n-3 LCPUFA supplementation during pregnancy does not influence the 
cognition, language or fine motor skills of children in late primary school (12 years of age). The 
significant differences observed in hand-eye coordination at 2½ years of age could no longer be detected, 
and may have been diluted by other environmental factors. Alternatively, the findings reported at  
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aged 2 ½ years may have represented a type I statistical error. This is in line with other recent findings 
published this year, including a large meta-analysis completed by Gould et al. [8], and the results of a 
large long-term follow up study completed by Makrides and colleagues [9].  
Fatty acid analyses indicate that the supplementation effect of raising n-3 LCPUFA status in cord 
blood was no longer present at 12 years. This suggests that the nutritional intake of the participants in the 
intervening years diluted the effect of the supplementation during pregnancy. Yet, akin to other reported 
correlational studies, current n-3 LCPUFA intake was important for neurological performance [10,11]. These 
results need to be interpreted with caution however, considering the low sample size relative to other 
published studies in this field.  
This current study has strength in being the longest follow-up of a maternal n-3 LCPUFA 
supplementation trial to date. Furthermore, this study used a well validated assessment protocol. 
However, there was a high attrition rate in our study, which was largely due to our inability to contact 
participants or due to a lack of interest in the study participants to attend. The reduced number of 
participants in this follow-up limits the statistical power of the study to identify treatment-related 
differences. Indeed, a near significant finding for externalising behaviours as reported by their parents 
may have reached significance in a larger cohort.  
5. Conclusions 
In conclusion, our data suggests that n-3 LCPUFA supplementation in pregnancy is ineffective for 
enhancing later childhood development in healthy children born at term. However, further studies with 
larger sample sizes are required to obtain more conclusive results.  
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